Preliminarily study of a novel porous composite: cytocompatibility in vitro and osteogenesis in vivo

Qian TANG,Jian-hong CHEN,Jian WU,Ping WANG,Zhu-li PENG,Huan-you LIANG,Xiao-feng CHEN,Gang WU
DOI: https://doi.org/10.3760/cma.j.issn.1674-1927.2010.01.013
2010-01-01
Abstract:Objective To study the cytocompatibility of poly (3-hydroxybutyrate-co-3 -hydroxyvalerate)/sol-gel bioactive glass (PHBV/SGBG)composite with bone marrow stromal cells in vitro, and the in vivo osteogenesis efficiency of PHBV/SGBG composite under periosteal flap in bone defect animal models. Methods The cytocompatibility of PHBV/SGBG composite was tested by MTT assay and direct contact assay. Of established tibial defect canine models, PHBV/SGBG composite was embedded into the defects of the experimental group, while no treatment was given to the control group. Samples were harvested at weeks 2,4, 8, and 12 post-surgery. The effect of osteogenesis was inspected by scanning electron microscope observation and energy-dispersive X-ray analysis. Results The cytotoxicity score of PHBV/SGBG composite in the serial dilution extract and different culture time ranked from grades 0 to 1. Marrow stem cells (MSCs) attached to and then adhered firmly on the surface of PHBV/SGBG composite, and proliferated rapidly, with obvious cell prominences stretching into the micro-pores structure. In the experimental group, formation of new bone islands was observed at week 2 post-surgery, and mature bone regeneration at week 12. Scanning electron microscopy and energy-dispersive X-ray analysis showed increasing calcium peak in the experiment group. At week 4 Ca/P ratio was 1.086±0.034 in experiment group and 0.793±0.053 in control group. At week 12 Ca/P ratio was 1.603±0.067 in experiment group and 1.456±0.036 in control group (P<0.05). Conclusions PHBV/SGBG shows no cytotoxicity to MSCs, and possesses good osteo-conductibility and regeneration capability. It may be a promising composite for bone tissue engineering.
What problem does this paper attempt to address?